| Year | Title | Author(s) |
| 2023 |
Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2
Cell Reports |
Adamska, JZ Verma, R Gupta, S Hagan, T Wimmers, F Floyd, K Li, Q Valore, EV Wang, YL Trisal, M Vilches-Moure, JG Subramaniam, S Walkley, CR Suthar, MS Li, JB Pulendran, B |
| 2021 |
Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
Lancet Respiratory Medicine |
Dixon, B Smith, RJ Campbell, DJ Moran, JL Doig, GS Rechnitzer, T MacIsaac, CM Simpson, N van Haren, FMP Ghosh, AN Gupta, S Broadfield, EJC Crozier, TME French, C Santamaria, JD |